FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078176077> ?p ?o ?g. }

• W2078176077 endingPage "422" @default.
• W2078176077 startingPage "412" @default.
• W2078176077 abstract "Aortic stiffness assessed by brachio-ankle pulse wave velocity (baPWV) can be used to predict cardiovascular events. However, baPWV is dependent on blood pressure. Antihypertensive drugs have been reported to reduce baPWV; but it is difficult to determine if this effect is associated with lowered blood pressure or reduced arterial stiffness.The primary end point of this study was to assess whether antihypertensive drugs reduce arterial stiffness as estimated by cardio-ankle vascular index (CAVI). The secondary end point was to compare the effects of 2 widely used drugs, the calcium-channel blocker amlodipine and the angiotensin II receptor blocker candesartan, on arterial stiffness.Between October 2005 and September 2006, consecutive Japanese outpatients with essential hypertension (EHT) (defined as using antihypertensive drugs at screening, systolic blood pressure [SBP] > 140 mm Hg, or diastolic BP [DBP] >90 mm Hg) were assigned to treatment for 24 weeks with either amlodipine (5-10 mg/d) or candesartan (8-12 mg/d). Arterial stiffness was evaluated with CAVI before and after 24 weeks of treatment. Relative change in arterial stiffness from baseline was also compared. The evaluator was blinded to treatment.Twenty patients (11 men, 9 women; mean [SD] age, 62 [10] years) were included in the study. There were no significant differences in clinical characteristics between the 2 groups. At baseline, mean (SD) CAVI was not significantly different in the amlodipine group compared with the candesartan group (8.93 [0.93] vs 8.46 [1.34], respectively). During the 24-week treatment period, mean SBP and DBP decreased significantly in both the amlodipine (14/10 mm Hg; P = 0.006 and P = 0.005) and the candesartan groups (13/11 mm Hg; P = 0.033 and P = 0.005). Amlodipine was associated with a significant change in CAVI from baseline (8.93 [0.93] vs 8.60 [1.50]; P = 0.017), whereas candesartan was not (8.46 [1.34] vs 8.81 [1.20]). The percentage change in CAVI was significantly different in the amlodipine group compared with the candesartan group (-7.14 [8.83] vs 5.85 [16.0], respectively; P = 0.038). After 24 weeks of treatment, the CAVI of the amlodipine group was still numerically larger than baseline CAVI of the candesartan group, although the difference was not statistically significant. Furthermore, there was no significant difference in absolute CAVI between the 2 groups after 24 weeks, but the relative change from baseline was significant in favor of amlodipine. Logistic regression analysis revealed that amlodipine improved CAVI independent of its antihypertensive effect.These data suggest that amlodipine and candesartan had different effects on aortic stiffness estimated by CAVI, despite similar effects on brachial blood pressure after 24 weeks of treatment in these Japanese patients with EHT." @default.
• W2078176077 created "2016-06-24" @default.
• W2078176077 creator A5007095901 @default.
• W2078176077 creator A5010681314 @default.
• W2078176077 creator A5037289392 @default.
• W2078176077 creator A5051602851 @default.
• W2078176077 creator A5058053099 @default.
• W2078176077 creator A5060462506 @default.
• W2078176077 creator A5062935260 @default.
• W2078176077 creator A5078454365 @default.
• W2078176077 creator A5080557596 @default.
• W2078176077 creator A5081357256 @default.
• W2078176077 date "2008-10-01" @default.
• W2078176077 modified "2023-09-28" @default.
• W2078176077 title "Effects of amlodipine and candesartan on arterial stiffness estimated by cardio-ankle vascular index in patients with essential hypertension: A 24-week study" @default.
• W2078176077 cites W1969992650 @default.
• W2078176077 cites W1984542647 @default.
• W2078176077 cites W1989015919 @default.
• W2078176077 cites W2003467903 @default.
• W2078176077 cites W2006408342 @default.
• W2078176077 cites W2006777248 @default.
• W2078176077 cites W2007631517 @default.
• W2078176077 cites W2020713751 @default.
• W2078176077 cites W2023247076 @default.
• W2078176077 cites W2043251741 @default.
• W2078176077 cites W2071870756 @default.
• W2078176077 cites W2074089489 @default.
• W2078176077 cites W2074618392 @default.
• W2078176077 cites W2080498471 @default.
• W2078176077 cites W2114634962 @default.
• W2078176077 cites W2118194784 @default.
• W2078176077 cites W2120179549 @default.
• W2078176077 cites W2125914602 @default.
• W2078176077 cites W2130177585 @default.
• W2078176077 cites W2141250561 @default.
• W2078176077 cites W2141870462 @default.
• W2078176077 cites W2147483495 @default.
• W2078176077 cites W2160187215 @default.
• W2078176077 cites W2161847205 @default.
• W2078176077 cites W2162042195 @default.
• W2078176077 cites W2771350904 @default.
• W2078176077 doi "https://doi.org/10.1016/j.curtheres.2008.10.002" @default.
• W2078176077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3969957" @default.
• W2078176077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24692816" @default.
• W2078176077 hasPublicationYear "2008" @default.
• W2078176077 type Work @default.
• W2078176077 sameAs 2078176077 @default.
• W2078176077 citedByCount "11" @default.
• W2078176077 countsByYear W20781760772013 @default.
• W2078176077 countsByYear W20781760772015 @default.
• W2078176077 countsByYear W20781760772016 @default.
• W2078176077 countsByYear W20781760772017 @default.
• W2078176077 countsByYear W20781760772019 @default.
• W2078176077 countsByYear W20781760772021 @default.
• W2078176077 crossrefType "journal-article" @default.
• W2078176077 hasAuthorship W2078176077A5007095901 @default.
• W2078176077 hasAuthorship W2078176077A5010681314 @default.
• W2078176077 hasAuthorship W2078176077A5037289392 @default.
• W2078176077 hasAuthorship W2078176077A5051602851 @default.
• W2078176077 hasAuthorship W2078176077A5058053099 @default.
• W2078176077 hasAuthorship W2078176077A5060462506 @default.
• W2078176077 hasAuthorship W2078176077A5062935260 @default.
• W2078176077 hasAuthorship W2078176077A5078454365 @default.
• W2078176077 hasAuthorship W2078176077A5080557596 @default.
• W2078176077 hasAuthorship W2078176077A5081357256 @default.
• W2078176077 hasBestOaLocation W20781760771 @default.
• W2078176077 hasConcept C126322002 @default.
• W2078176077 hasConcept C164705383 @default.
• W2078176077 hasConcept C17140001 @default.
• W2078176077 hasConcept C2775850156 @default.
• W2078176077 hasConcept C2777097880 @default.
• W2078176077 hasConcept C2778319312 @default.
• W2078176077 hasConcept C2779646130 @default.
• W2078176077 hasConcept C2780036600 @default.
• W2078176077 hasConcept C2780356492 @default.
• W2078176077 hasConcept C2908929049 @default.
• W2078176077 hasConcept C71924100 @default.
• W2078176077 hasConcept C84393581 @default.
• W2078176077 hasConceptScore W2078176077C126322002 @default.
• W2078176077 hasConceptScore W2078176077C164705383 @default.
• W2078176077 hasConceptScore W2078176077C17140001 @default.
• W2078176077 hasConceptScore W2078176077C2775850156 @default.
• W2078176077 hasConceptScore W2078176077C2777097880 @default.
• W2078176077 hasConceptScore W2078176077C2778319312 @default.
• W2078176077 hasConceptScore W2078176077C2779646130 @default.
• W2078176077 hasConceptScore W2078176077C2780036600 @default.
• W2078176077 hasConceptScore W2078176077C2780356492 @default.
• W2078176077 hasConceptScore W2078176077C2908929049 @default.
• W2078176077 hasConceptScore W2078176077C71924100 @default.
• W2078176077 hasConceptScore W2078176077C84393581 @default.
• W2078176077 hasIssue "5" @default.
• W2078176077 hasLocation W20781760771 @default.
• W2078176077 hasLocation W20781760772 @default.
• W2078176077 hasLocation W20781760773 @default.
• W2078176077 hasLocation W20781760774 @default.
• W2078176077 hasOpenAccess W2078176077 @default.
• W2078176077 hasPrimaryLocation W20781760771 @default.
• W2078176077 hasRelatedWork W2078176077 @default.

• next